From CTV News:
A little-known antiviral drug that works against influenza has been largely ignored as countries race to amass drug arsenals to fight a feared flu pandemic. But governments should not overlook zanamivir, a commentary in a leading medical journal suggests.
The commentary, in this week's issue of The Lancet, appears almost prescient; Germany announced Thursday it was buying 1.7 million doses of zanamivir, choosing it over the more popular antiviral oseltamivir. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment